• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

狼疮患者血清对肾小球内皮纤维蛋白溶解系统的影响。

Effect of sera from lupus patients on the glomerular endothelial fibrinolysis system.

机构信息

Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Department of Vascular Biology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

出版信息

Pediatr Int. 2022 Jan;64(1):e15099. doi: 10.1111/ped.15099.

DOI:10.1111/ped.15099
PMID:35522716
Abstract

BACKGROUND

Dysregulation of the coagulation fibrinolysis system in resident glomerular cells is associated with the pathogenesis of lupus nephritis. However, the role of plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator (tPA) in resident glomerular cells remains undetermined.

METHODS

We examined the expression of PAI-1 and tPA mRNA in cultured normal human glomerular endothelial cells (GECs) treated with serum from patients with systemic lupus erythematosus (SLE) using quantitative reverse transcription polymerase chain reactions. We determined the relationship between PAI-1/tPA mRNA expression and several clinical/laboratory parameters. Serum from 16 patients (nine patients with new-onset SLE and seven patients with stable SLE) was used in the study.

RESULTS

Plasminogen activator inhibitor-1 and tPA mRNA expression was significantly higher in GECs treated with serum of patients with new-onset SLE than other groups. The PAI-1 and tPA mRNA levels were also significantly correlated in GECs treated with serum from patients with SLE. Interestingly, both PAI-1 and tPA mRNA levels in GECs were inversely correlated with serum C4 level and positively correlated with SLE disease activity.

CONCLUSIONS

These results suggest that serum from patients with SLE may activate the fibrinolysis system in glomerulus, which may be involved in the pathogenesis of lupus nephritis.

摘要

背景

固有肾小球细胞中凝血纤溶系统的失调与狼疮肾炎的发病机制有关。然而,纤溶酶原激活物抑制剂-1(PAI-1)和组织型纤溶酶原激活物(tPA)在固有肾小球细胞中的作用仍未确定。

方法

我们使用定量逆转录聚合酶链反应检测了用系统性红斑狼疮(SLE)患者血清处理的培养的正常人肾小球内皮细胞(GEC)中 PAI-1 和 tPA mRNA 的表达。我们确定了 PAI-1/tPA mRNA 表达与几个临床/实验室参数之间的关系。该研究使用了 16 名患者(9 名新发 SLE 患者和 7 名稳定 SLE 患者)的血清。

结果

与其他组相比,用新发病例 SLE 患者血清处理的 GEC 中 PAI-1 和 tPA mRNA 的表达明显更高。在用 SLE 患者血清处理的 GEC 中,PAI-1 和 tPA mRNA 水平也呈显著相关。有趣的是,GEC 中的 PAI-1 和 tPA mRNA 水平与血清 C4 水平呈负相关,与 SLE 疾病活动呈正相关。

结论

这些结果表明,SLE 患者的血清可能激活肾小球中的纤溶系统,这可能与狼疮肾炎的发病机制有关。

相似文献

1
Effect of sera from lupus patients on the glomerular endothelial fibrinolysis system.狼疮患者血清对肾小球内皮纤维蛋白溶解系统的影响。
Pediatr Int. 2022 Jan;64(1):e15099. doi: 10.1111/ped.15099.
2
Chloroquine attenuates TLR3-mediated plasminogen activator inhibitor-1 expression in cultured human glomerular endothelial cells.氯喹可减弱培养的人肾小球内皮细胞中TLR3介导的纤溶酶原激活物抑制剂-1的表达。
Clin Exp Nephrol. 2019 Apr;23(4):448-454. doi: 10.1007/s10157-018-1659-y. Epub 2018 Oct 20.
3
Disturbances in the tissue plasminogen activator/plasminogen activator inhibitor (TPA/PAI) system in systemic lupus erythematosus.系统性红斑狼疮中组织型纤溶酶原激活物/纤溶酶原激活物抑制剂(TPA/PAI)系统的紊乱
Am J Hematol. 1991 May;37(1):9-13. doi: 10.1002/ajh.2830370104.
4
Role of fibrinolytic parameters and plasminogen activator inhibitor 1 (PAI-1) promoter polymorphism on premature atherosclerosis in SLE patients.纤维蛋白溶解参数和纤溶酶原激活物抑制剂 1(PAI-1)启动子多态性在系统性红斑狼疮患者早发动脉粥样硬化中的作用。
Lupus. 2011 Oct;20(10):1063-71. doi: 10.1177/0961203311404911. Epub 2011 Jun 30.
5
Expression of glomerular plasminogen activator inhibitor type 1 in glomerulonephritis.肾小球肾炎中1型肾小球纤溶酶原激活物抑制剂的表达
Am J Kidney Dis. 2002 Apr;39(4):695-705. doi: 10.1053/ajkd.2002.31986.
6
Expression of type 1 plasminogen activator inhibitor in renal tissue in murine lupus nephritis.1型纤溶酶原激活物抑制剂在小鼠狼疮性肾炎肾组织中的表达
Kidney Int. 1995 Jan;47(1):148-57. doi: 10.1038/ki.1995.17.
7
TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.TM5275 延长了分泌型组织型纤溶酶原激活物的保留时间,并增强了血管内皮细胞的纤溶作用。
Thromb Res. 2013 Jul;132(1):100-5. doi: 10.1016/j.thromres.2013.04.003. Epub 2013 Apr 20.
8
Preservation of peritoneal fibrinolysis owing to decreased transcription of plasminogen activator inhibitor-1 in peritoneal mesothelial cells suppresses postoperative adhesion formation in laparoscopic surgery.由于腹腔间皮细胞中纤溶酶原激活物抑制剂-1 的转录减少,导致腹腔内纤维蛋白溶解作用得以保存,从而抑制了腹腔镜手术后的粘连形成。
Surgery. 2013 Mar;153(3):344-56. doi: 10.1016/j.surg.2012.07.037. Epub 2012 Dec 4.
9
Induction of plasminogen activator inhibitor type 1 in murine lupus-like glomerulonephritis.小鼠狼疮样肾小球肾炎中1型纤溶酶原激活物抑制剂的诱导
Kidney Int. 1995 Nov;48(5):1459-68. doi: 10.1038/ki.1995.435.
10
Plasminogen Activator Inhibitor-1 Reduces Tissue-Type Plasminogen Activator-Dependent Fibrinolysis and Intrahepatic Hemorrhage in Experimental Acetaminophen Overdose.纤溶酶原激活物抑制剂-1 可减少组织型纤溶酶原激活物依赖的纤维蛋白溶解和实验性对乙酰氨基酚过量引起的肝内出血。
Am J Pathol. 2018 May;188(5):1204-1212. doi: 10.1016/j.ajpath.2018.01.010. Epub 2018 Feb 16.

引用本文的文献

1
Lupus Nephritis from Pathogenesis to New Therapies: An Update.狼疮性肾炎:从发病机制到新疗法的研究进展。
Int J Mol Sci. 2024 Aug 18;25(16):8981. doi: 10.3390/ijms25168981.